Investor Home

Stock Quote
MNOV (Common)
ExchangeNASDAQ (US Dollar)
Price$1.80
Change (%) Stock is Down 0.01 (0.55%)
Volume4,440
Data as of 01/27/12 12:59 p.m. ET
Minimum 20 minute delay
Refresh quote
Corporate Profile
MediciNova, Inc. is a publicly-traded biopharmaceutical company focused on acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet need with a specific focus on the U.S. market. Through strategic alliances primarily with Japanese pharmaceutical companies, MediciNova holds rights to a diversified portfolio of clinical and preclinical product candidates, each of which MediciNova believes has a well-characterized and differentiated therapeutic profile, ... More >>
Recent NewsMore >>
MediciNova and University of Colorado Boulder Collaborate on Potential Novel Therapy for Traumatic Brain Injury - 01/16/12
SAN DIEGO, Jan 16, 2012 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), and the University of ... More >>
MediciNova, Inc. Appoints Kousuke Nakata to Its Board of Directors - 11/30/11
SAN DIEGO, Calif., Nov 30, 2011 (GlobeNewswire via COMTEX) -- MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), today announced the appointmen... More >>
MediciNova Reports Third Quarter 2011 Results - 11/15/11
MediciNova Management to Host a Conference Call to Discuss Third Quarter 2011 Results Today, November 15, at 4:30pm (EST) SAN DIEGO, Nov 15, 2011 (GlobeNewswire via COMTEX) -- MediciNova, Inc., a biopharmaceutical company that is publicly... More >>
MediciNova to Present at the Lazard Capital Markets Healthcare Conference - 11/09/11
SAN DIEGO, Nov 9, 2011 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company that is publicly traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (Code Number: 4875), today anno... More >>
MediciNova Announces Repeat Dose Clinical Trial With MN-221 in Chronic Obstructive Pulmonary Disease (COPD) Patients - 10/27/11
SAN DIEGO, Oct 27, 2011 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), announced initiation of a Phase 1b clin... More >>
MediciNova to Receive $2.5 Million Payment From Kissei Pharmaceutical Co. Ltd. to Expand Clinical Development of the MN-221 Program - 10/13/11
MediciNova Management to Host a Business Update Conference Call Monday, October 17, at 4:30pm (EDT) SAN DIEGO, Oct 13, 2011 (GlobeNewswire via COMTEX) --MediciNova Inc., a biopharmaceutical company publicly traded on the NASDAQ Global Market (Nasd... More >>
MediciNova Closes $7.5 Million Private Stock Sale to Kissei Pharmaceutical Co., Ltd. - 10/12/11
SAN DIEGO, Oct 12, 2011 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), announced it has closed the private sto... More >>
MediciNova, Inc. Announces Private Sale of Stock to Kissei Pharmaceutical Co., Ltd. - 09/26/11
SAN DIEGO, Sep 26, 2011 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), today announced a private offering of c... More >>
MediciNova, Inc. Appoints Mr. Tatsuo Izumi to Its Board of Directors - 09/26/11
SAN DIEGO, Sep 26, 2011 (GlobeNewswire via COMTEX) --MediciNova, Inc., a biopharmaceutical company traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Market of the Osaka Securities Exchange (4875), today announced the appointment of Mr. ... More >>
MediciNova Announces Management Appointments - 09/02/11
Appointment of Chief Medical Officer and Chief Financial Officer SAN DIEGO, Sep 2, 2011 (GlobeNewswire via COMTEX) -- MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market (Nasdaq:MNOV) and the Jasdaq Ma... More >>
Upcoming EventsMore >>
There are currently no events scheduled.
What's New
There are currently no items available.
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Medicinova Inc posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Investor Tools

Print Page Print Page
E-mail Page E-mail Page
RSS Feeds RSS Feeds
E-mail Alerts E-mail Alerts
IR Contacts IR Contacts


Stock Information

MNOV (Common)
$1.80   - 0.01		01/27/12
12:59 p.m. ET

Medicinova